TCOTO
BIIB icon

Trust Company of the Ozarks’s Biogen BIIB Stock Holding History

Trust Company of the Ozarks’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$223K Buy
765
+90
+13% +$29.7K 0.08% 156
2015
Q2 		$273K Buy
675
+120
+22% +$48.2K 0.08% 155
2015
Q1 		$234K Buy
+555
New +$219K 0.06% 159

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Trust Company of the Ozarks's BIIB Position: Q3 2015 in Review

Trust Company of the Ozarks increased its Biogen (BIIB) stake by 13% in Q3 2015, buying an estimated $29.7K and bringing the position to 765 shares worth $223K. The position accounts for 0.08% of the portfolio, ranked #156.

Trust Company of the Ozarks first reported a position in BIIB in Q1 2015 and has held it in 3 quarters since. The position peaked at $273K in Q2 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Trust Company of the Ozarks held 765 shares of Biogen worth $223K as of Q3 2015.
  • Trust Company of the Ozarks bought 90 Biogen shares in Q3 2015, an estimated $29.7K.
  • Biogen made up 0.08% of Trust Company of the Ozarks's portfolio in Q3 2015, its #156 holding.
  • Trust Company of the Ozarks first reported a position in Biogen in Q1 2015 and has held it in 3 quarters since.
  • Trust Company of the Ozarks's Biogen position peaked at $273K in Q2 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.